Literature DB >> 28467285

Hypothalamic or Extrahypothalamic Modulation and Targeted Temperature Management After Brain Injury.

Rishabh Charan Choudhary1, Xiaofeng Jia1,2,3,4,5.   

Abstract

Targeted temperature management (TTM) has been recognized to protect tissue function and positively influence neurological outcomes after brain injury. While shivering during hypothermia nullifies the beneficial effect of TTM, traditionally, antishivering drugs or paralyzing agents have been used to reduce the shivering. The hypothalamic area of the brain helps in controlling cerebral temperature and body temperature through interactions between different brain areas. Thus, modulation of different brain areas either pharmacologically or by electrical stimulation may contribute in TTM; although, very few studies have shown that TTM might be achieved by activation and inhibition of neurons in the hypothalamic region. Recent studies have investigated potential pharmacological methods of inducing hypothermia for TTM by aiming to maintain the TTM and reduce the shivering effect without using antiparalytic drugs. Better survival and neurological outcome after brain injury have been reported after pharmacologically induced TTM. This review discusses the mechanisms and modulation of the hypothalamus with other brain areas that are involved in inducing hypothermia through which TTM may be achieved and provides therapeutic strategies for TTM after brain injury.

Entities:  

Keywords:  brain injury; electrical stimulation; hypothalamus; pharmacological-induced hypothermia; targeted temperature management; therapeutic hypothermia

Mesh:

Year:  2017        PMID: 28467285      PMCID: PMC5610405          DOI: 10.1089/ther.2017.0003

Source DB:  PubMed          Journal:  Ther Hypothermia Temp Manag        ISSN: 2153-7658            Impact factor:   1.286


  118 in total

Review 1.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

Review 2.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

3.  Transient receptor potential TRP channels as therapeutic drug targets: next round!

Authors:  Bernd Nilius
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 4.  Part 8: Post-Cardiac Arrest Care: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Clifton W Callaway; Michael W Donnino; Ericka L Fink; Romergryko G Geocadin; Eyal Golan; Karl B Kern; Marion Leary; William J Meurer; Mary Ann Peberdy; Trevonne M Thompson; Janice L Zimmerman
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

5.  2-Deoxy-D-glucose-induced hypothermia in anesthetized rats: Lack of forebrain contribution and critical involvement of the rostral raphe/parapyramidal regions of the medulla oblongata.

Authors:  Toshimasa Osaka
Journal:  Brain Res Bull       Date:  2015-07-02       Impact factor: 4.077

6.  Role of nitric oxide in insulin-induced hypothermia in rats.

Authors:  M C Almeida; L G Branco
Journal:  Brain Res Bull       Date:  2001-01-01       Impact factor: 4.077

Review 7.  The efficacy and safety of prehospital therapeutic hypothermia in patients with out-of-hospital cardiac arrest: A systematic review and meta-analysis.

Authors:  Fang-Yang Huang; Bao-Tao Huang; Peng-Ju Wang; Zhi-Liang Zuo; Yue Heng; Tian-Li Xia; Yi-Yue Gui; Wen-Yu Lv; Chen Zhang; Yan-Biao Liao; Wei Liu; Mao Chen; Ye Zhu
Journal:  Resuscitation       Date:  2015-08-21       Impact factor: 5.262

8.  Beneficial effects of nitric oxide on outcomes after cardiac arrest and cardiopulmonary resuscitation in hypothermia-treated mice.

Authors:  Kotaro Kida; Kazuhiro Shirozu; Binglan Yu; Joseph B Mandeville; Kenneth D Bloch; Fumito Ichinose
Journal:  Anesthesiology       Date:  2014-04       Impact factor: 7.892

Review 9.  Dorsomedial hypothalamic NPY modulation of adiposity and thermogenesis.

Authors:  Sheng Bi
Journal:  Physiol Behav       Date:  2013-04-03

10.  European society of intensive care medicine study of therapeutic hypothermia (32-35 °C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial).

Authors:  Peter J D Andrews; Helen Louise Sinclair; Claire G Battison; Kees H Polderman; Giuseppe Citerio; Luciana Mascia; Bridget A Harris; Gordon D Murray; Nino Stocchetti; David K Menon; Haleema Shakur; Daniel De Backer
Journal:  Trials       Date:  2011-01-12       Impact factor: 2.279

View more
  5 in total

1.  Therapeutic Hypothermia and Targeted Temperature Management With or Without the "Cold Stress" Response.

Authors:  Patrick M Kochanek; Travis C Jackson
Journal:  Ther Hypothermia Temp Manag       Date:  2017-08-11       Impact factor: 1.286

Review 2.  Positron Emission Tomography After Ischemic Brain Injury: Current Challenges and Future Developments.

Authors:  Zhuoran Wang; Conrad Mascarenhas; Xiaofeng Jia
Journal:  Transl Stroke Res       Date:  2020-01-14       Impact factor: 6.829

Review 3.  Targeted temperature management and early neuro-prognostication after cardiac arrest.

Authors:  Songyu Chen; Brittany Bolduc Lachance; Liang Gao; Xiaofeng Jia
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

Review 4.  Pharmacological Approach for Neuroprotection After Cardiac Arrest-A Narrative Review of Current Therapies and Future Neuroprotective Cocktail.

Authors:  Rishabh C Choudhary; Muhammad Shoaib; Samantha Sohnen; Daniel M Rolston; Daniel Jafari; Santiago J Miyara; Kei Hayashida; Ernesto P Molmenti; Junhwan Kim; Lance B Becker
Journal:  Front Med (Lausanne)       Date:  2021-05-18

5.  Pharmacological induced target temperature management after cardiac arrest: the capsaicinoids.

Authors:  J Marc Simard; Xiaofeng Jia; Volodymyr Gerzanich
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.